Full history for every metric is available with a Kvantra account

Stock profile

Endymed Ltd (ENDY.TA)

Country: United States of AmericaSector: HealthcareIndustry: Medical - DevicesExchange: TLV

Delisted · last close 16 Feb 2025

Current price
320.10 ILA0.00%
Last close 16 Feb 2025
Benchmarks

Key financial summary

Financials in USD
201820192020202120222023TTM
Total revenue$m18161422212319
Operating profit$m1-2
Net profit$m220511-2
EPS reported$0.04-0.13
Operating cashflow per share$-0.05-0.05
Capex per share$0.000.00
FCF per share$-0.05-0.05
Free cash flow$m-1-2
Net debt$m-10-7
Book value equity$m1513
Book value per share$1.110.96
Number of sharesm13.8113.76
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
201820192020202120222023TTM
Value
P/E TTMx20.60-
P/B LTMx0.771.09
P/S LTMx0.510.76
P/FCF LTMx-16.58-6.21
EV/EBITDA LTMx2.11-5.01
EV/Sales LTMx0.140.39
Earnings Yield LTM%4.85%3.83%
FCF Yield%-6.03%-16.09%
Quality
ROE%3.62%3.69%
ROIC%2.87%2.87%
Operating margin%4.05%4.05%
Gross margin%51.20%51.20%
FCF/Sales%-3.09%-3.09%
Growth and momentum
EPS Growth YoY%-34.26%-
Sales Growth YoY%+6.77%-17.00%
Net Income Growth YoY%-34.94%-
FCF Growth%--
Operating Profit Growth%-32.55%-
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx-0.55-2.03
Net Debt/EBITDAx-5.52-5.52
EBIT/Net interestx25.6125.61
Net debt/market cap%-83.29%-48.36%
Net debt/Equityx-0.64-0.53
Gross debt/equityx0.080.09

Company overview

Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.

WebsiteN/A
IndustryMedical - Devices
Trades inILA

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 16 Feb 2025

Endymed Ltd (ENDY.TA)

ENDY.TA · TLV · Healthcare
320.10 ILA0.00%
Benchmarks
Financialsin USD
20222023TTM
About

Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.

IndustryMedical - Devices
Trades inILA

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free